Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00477750 · BASELINE

Baseline characteristics

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma · Source last updated 2019-10-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      26
    units
    Participants
groups
  1. description
    Intervention: Drug: lenalidomide 10 mg orally days 1-21 every 28 days until progression Intervention: Drug: melphalan 5mg/m\^2 orally days 1-4 every 28 days until progression Intervention: Drug: prednisone 60mg/m\^2, orally days 1-4 every 28 days until progression
    id
    BG000
    title
    Treatment (Lenalidomide, Melphalan, Prednisone)
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          64
          upper Limit
          87
          value
          73.5
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          9
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          17
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          26
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      I - Low Cell Mass
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      II - Intermediate Cell Mass
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      III - High Cell Mass
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      unknown
    param Type
    NUMBER
    title
    Durie-Salmon Stage at Diagnosis
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          20
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      No
    param Type
    NUMBER
    title
    Parameter of Hematologic Response - Serum M-spike >= 1g/dL
    unit Of Measure
    participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          14
      title
      No
    param Type
    NUMBER
    title
    Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10mg/dL
    unit Of Measure
    participants
  7. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          20
      title
      No
    param Type
    NUMBER
    title
    Parameter of Hematologic Response - Urine M-spike >= 200 mg/24 hours
    unit Of Measure
    participants
  8. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          26
      title
      No
    param Type
    NUMBER
    title
    Parameter of Hematologic Response - None (non-secretory myeloma, bone marrow only)
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      26
    units
    Participants
groups
  1. description
    Intervention: Drug: lenalidomide 10 mg orally days 1-21 every 28 days until progression Intervention: Drug: melphalan 5mg/m\^2 orally days 1-4 every 28 days until progression Intervention: Drug: prednisone 60mg/m\^2, orally days 1-4 every 28 days until progression
    id
    BG000
    title
    Treatment (Lenalidomide, Melphalan, Prednisone)
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          64
          upper Limit
          87
          value
          73.5
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          9
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          17
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          26
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      I - Low Cell Mass
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      II - Intermediate Cell Mass
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      III - High Cell Mass
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      unknown
    param Type
    NUMBER
    title
    Durie-Salmon Stage at Diagnosis
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          20
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      No
    param Type
    NUMBER
    title
    Parameter of Hematologic Response - Serum M-spike >= 1g/dL
    unit Of Measure
    participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          14
      title
      No
    param Type
    NUMBER
    title
    Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10mg/dL
    unit Of Measure
    participants
  7. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          20
      title
      No
    param Type
    NUMBER
    title
    Parameter of Hematologic Response - Urine M-spike >= 200 mg/24 hours
    unit Of Measure
    participants
  8. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          26
      title
      No
    param Type
    NUMBER
    title
    Parameter of Hematologic Response - None (non-secretory myeloma, bone marrow only)
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice